Nephrotoxicity of isosorbide dinitrate and cholestasis in rat: The possible role of nitric oxide

Iranian Journal of Medical Sciences

Volumn 29, Issue 2, 2004, Pages 75-80

  Sharifi, Ali Mohammad ^a,c   Akbarloo, N ^a   Sasani, F ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholestasis; Nephrotoxicity; Nitric oxide

Indexed keywords

4 NITROPHENYL N ACETYL BETA DEXTRO GLUCOSAMINIDASE; CREATININE; ISOSORBIDE DINITRATE; N ACETYL BETA GLUCOSAMINIDASE; NITRIC OXIDE; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CHOLESTASIS; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; GLOMERULUS; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; RAT; URINARY EXCRETION; URINE LEVEL;

EID: 10644293945     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Palier MS. Nitric oxide-mediated renal epithelial cell injury during hypoxia and reoxygenation. Ren Fail 1998; 20: 459-9.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
3. Baylis C, Bloch J. Nitric oxide (NO) in renal physiology and pathophysiology. Nephrol Dial Transplant 1996; 11: 1955-8.
4. Yu L. Role of Nitric oxide in acute renal failure. Renal Failure 1997; 19: 213-6.
5. MacAllister R, Vallance P. Nitric oxide in essential and renal hypertension. J. Am. Soc. Nephrol 1994; 5: 1057-65
6. Radi R, Beckman JS, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys 1991; 288: 481-7.
7. Forsterman U, Pollock JS, Nakane M. Nitric oxide synthesis in the cardiovascular system. Trends. Cardiovasc Med 1993; 3: 104-10.
8. Morrissey JJ, McCracken R, Kaneto H, Vehaskari M. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994; 45: 998-1005.
9. Shultz PJ, Archier SL, Rosenberg ME. Inducible nitric oxide synthase mRNA and activity in glomerular mesangial cells. Kidney Int 1994; 46: 683-9.
10. Raij L, Jaimes D, Castillo D, et al. Pathophysiology of the vascular wall: The role of nitric oxide in renal disease, Prostaglandins. Leukotriens and Essential Fatty Acids 1996; 54: 53-8.
11. Ribeiro L, de Assuncao E, Silva F, et al. Evaluation of the nitric oxide production in rat renal artery smooth muscle cells culture exposed to radiocontrast agents. Kidney International 2004; 65: 589-96.
12. Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int 1995; 48: 20-32.
13. Abrams GA, Trauner M, Nathanson MH: Nitric oxide and liver disease. Gastroentrologist 1995; 3: 220-3.
14. Inan M, Sayek I, Tel BC, Sahin I. Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstructive jaundice. Br. J. Surg 1997; 84: 943-7.
15. Garvey MJ, Tuason VB, Hwang S. Use of renal enzymes to evaluate nephrotoxicity in lithium treated patients. Br. J. Psychiat 1982; 141: 420-2.
16. Lim CW. N-acetyl-B-D-glucosaminidase assay by the p-nitro-phenol- technique: Inhibitory effects of urine as decreased by gel filtration and by simple dilution. Clin Chem 1987; 33: 713-4.
17. Bergasa, NV, Rothman RB, Vergalla H, et al. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 1992; 15: 220-4.
18. Horak E, Hopfer SE, Sunderman FW. Spectraphotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem 1981; 27: 1180-5.
19. Jung K, Klotz S. More about determination of N-acetyl-B-D-glucosaminidase activity in urine without pretreatment of samples. Clin. Chem 1988; 34: 1002-6.
20. Noto A, Morita A, Numata Y, Kosugi Y. Stabilities of N-acetyl- beta- D-glucosaminidase (NAG) isoenzymes in urine: advantage of NAG isoenzyme B measurement in clinical applications. Clin. Chim. Acta 1998; 278: 35-43.
21. Valdivielso JM, Blantz RC. Acute renal failure: is nitric oxide the bad guy? Antioxid Redox Signal 2002; 4: 925-34.
22. Peer G, Blum M, Iaina A. Nitric oxide and acute renal failure. Nephron 1996; 73: 375-81.
23. Dagher F, Pollina RM, Rogers DM, et al. The value and limitations of L-arginine infusion on glomerular and tubular function in the ischemic/reperfused kidney. J Vasc Surg 1995; 21: 453-8.
24. Schramm L, Heidbreder E, Schmitt A, Heidland. A Role of L-arginine-drived NO in ischemic acute renal failure in the rat. Renal Failure 1994; 16: 555-9.
25. Saad SY, Najjar TA, Daba MH, Al-Rikabi AC. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy 2002; 48: 309-15.
26. Koppenol WH, Moreno JJ, Prior WA, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide, Chem. Res. Toxicol 1992; 5: 834-42.
27. Beckman JS, Beckman TW, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrites implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. USA 1990; 87: 1620-4.
28. Xiao L, Eneroth PH, Qureshi GA. Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand. J. Immunol 1995; 42: 505-11.
29. Pacelli R, Wink DA, Cook JA, and Mitchell JB. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med 1995; 182: 1469-79.
30. Estevez AG, Radi R., Barbeito L, Beckman JS. Peroxynitrite-induced cytotoxicity in PC12 cells, evidence for an apoptotic mechanism differentially modulated by neutrophic factors. J. Neurochem 1995; 65: 1543-50.
31. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996; 97: 2377-83.